Shingo Harada, Ryota Kajihara, Risa Muramoto, Promsuk Jutabha, Naohiko Anzai, Tetsuhiro Nemoto
文献索引:10.1016/j.bmcl.2018.03.075
全文:HTML全文
p-Boronophenylalanine (L-BPA) is applied in clinical settings as a boron carrier for boron neutron capture therapy (BNCT) to cure malignant melanomas. Structural modification or derivatization of L-BPA, however, to improve its uptake efficiency into tumor cells has scarcely been investigated. We successfully synthesized (S)-2-amino-3-(4-boronophenyl)-2-methylpropanoic acid in enantioenriched form as a novel candidate molecule for BNCT. Key steps to enhance the efficiency of this synthesis were enantioselective alkylation of N-protected alanine tert-butyl ester with a Maruoka catalyst and Miyaura borylation reaction to install the boron functionality.
|
Design, synthesis, evaluation, and molecular docking of urso...
2018-04-11 [10.1016/j.bmcl.2018.04.021] |
|
Covalent inhibitors of nicotinamide N-methyltransferase (NNM...
2018-04-10 [10.1016/j.bmcl.2018.04.017] |
|
Valproic Acid Induces Three Novel Cytotoxic Secondary Metabo...
2018-04-10 [10.1016/j.bmcl.2018.04.018] |
|
Agonists of the γ-Aminobutyric Acid Type B (GABAB) Receptor ...
2018-04-07 [10.1016/j.bmcl.2018.04.003] |
|
Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 rece...
2018-04-04 [10.1016/j.bmcl.2018.03.084] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2026 ChemSrc All Rights Reserved